A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
Breast Cancer Res Treat
; 155(3): 521-30, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-26875185
Full text:
1
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Breast Neoplasms
/
Esophageal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Heterocyclic Compounds, 3-Ring
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2016
Type:
Article
Affiliation country:
United States